JP7837658B2 - Cleansing wipes - Google Patents
Cleansing wipesInfo
- Publication number
- JP7837658B2 JP7837658B2 JP2022023267A JP2022023267A JP7837658B2 JP 7837658 B2 JP7837658 B2 JP 7837658B2 JP 2022023267 A JP2022023267 A JP 2022023267A JP 2022023267 A JP2022023267 A JP 2022023267A JP 7837658 B2 JP7837658 B2 JP 7837658B2
- Authority
- JP
- Japan
- Prior art keywords
- mass
- aqueous composition
- cleaning sheet
- content
- glyceryl caprate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/34—Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
- A01N33/02—Amines; Quaternary ammonium compounds
- A01N33/12—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/06—Unsaturated carboxylic acids or thio analogues thereof; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
- A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
- A01N47/44—Guanidine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P3/00—Fungicides
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47K—SANITARY EQUIPMENT; ACCESSORIES THEREFOR, e.g. TOILET ACCESSORIES
- A47K7/00—Body washing or cleaning implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- General Chemical & Material Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dentistry (AREA)
- Birds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
Description
本発明は、保存性向上剤と可溶化剤を含む水系組成物が基材シートに含浸された清拭シートに関する。 This invention relates to a cleaning sheet in which a base sheet is impregnated with an aqueous composition containing a preservative enhancer and a solubilizer.
従来から、乳幼児や被介護者の使い捨ておむつ等の交換時に汚れの拭き取りを容易にするために、又は汚れが付いた手や身体を拭き取るためにウェットタイプの清拭シートが使用されている。ウェットタイプの清拭シートは、通常、精製水中に抗菌剤等を含む水系組成物を基材シートに含浸して作製される。 Traditionally, wet-type cleansing wipes have been used to facilitate the wiping away of dirt during diaper changes for infants and those receiving care, or to wipe away dirt from hands and bodies. Wet-type cleansing wipes are typically manufactured by impregnating a base sheet with an aqueous composition containing antibacterial agents in purified water.
前記水系組成物は、肌に対する刺激を低減するために、精製水中の抗菌剤等の含有量が少ないことが望まれる。特に、乳幼児や肌の弱い老人に使用する清拭シートには、刺激のある成分の含有量が極力少なく、かつ精製水濃度の高い水系組成物が含侵されていることが望まれる。一方、精製水濃度の高い水系組成物が含侵された清拭シートは、保存期間の長期化に伴い細菌やカビが発生して、保存安定性が低下するおそれがある。 The aforementioned aqueous composition should ideally contain a low amount of antibacterial agents and other substances in the purified water to reduce skin irritation. In particular, for cleansing wipes used by infants and elderly people with sensitive skin, it is desirable that the aqueous composition impregnates the wipes with the lowest possible amount of irritating ingredients and a high concentration of purified water. On the other hand, cleansing wipes impregnated with an aqueous composition with a high concentration of purified water may experience a decrease in storage stability due to the growth of bacteria and mold over extended storage periods.
下記の特許文献1から特許文献3には、抗菌剤等を含む水溶液組成物が開示されている。
下記特許文献1には、化粧品等の抗菌・防腐剤として従来から広く使用されてきた、パラベン(パラヒドロキシ安息香酸エステル)は、界面活性剤等の可溶化剤の添加が必要であったが、可溶化剤が添加されると、パラベンの抗菌・防腐力が著しく低下することが記載されている。そこで、該特許文献1にはパラベンを含有しない、(A)成分として2,2-ビス(ヒドロキシメチル)プロピオン酸n-ヘキシルが0.2質量%以上と、(B)成分として炭素数6-8のアルキルグリセリルエーテル及び/又は炭素数8から12の脂肪酸グリセリルエステルが前記(A)成分の2倍以上含まれる皮膚外用剤が開示されている。前記脂肪酸グリセリルエステルとしてカプリン酸グリセリルが挙げられている。
Patent documents 1 to 3 below disclose aqueous solutions containing antibacterial agents and the like.
Patent Document 1, described below, states that parabens (parahydroxybenzoic acid esters), which have been widely used as antibacterial and preservative agents in cosmetics and the like, require the addition of solubilizers such as surfactants, but that the antibacterial and preservative power of parabens is significantly reduced when solubilizers are added. Therefore, Patent Document 1 discloses a topical skin preparation that does not contain parabens, in which component (A) is 0.2% by mass or more of 2,2-bis(hydroxymethyl)propionic acid n-hexyl, and component (B) is at least twice the amount of C6-C8 alkyl glyceryl ether and/or C8-C12 fatty acid glyceryl ester. Caprylic acid glyceryl is given as an example of the fatty acid glyceryl ester.
下記特許文献2には、パーソナルケア組成物として、環境持続性及び健康上の懸念のあるトリクロサンを含まない、カチオン性活性成分、カチオン適合性界面活性剤、泡促進剤、泡構造強化剤、及び哺乳類の皮膚組織への刺激を低減する皮膚調整剤を含む、発泡抗菌性皮膚洗剤が開示されている。前記泡促進剤として、カプリン酸グリセリルが挙げられている。下記特許文献3には、グリセリン脂肪酸エステル等と第4級アンモニウム塩を含有する、おしぼり又はウェットティシュー用の保存剤が開示されている。 Patent Document 2 discloses a foaming antimicrobial skin detergent as a personal care composition, which does not contain triclosan, a substance of environmental sustainability and health concern, and includes a cationic active ingredient, a cationic compatible surfactant, a foam promoter, a foam structure strengthening agent, and a skin modifier that reduces irritation to mammalian skin tissue. Glyceryl caprate is cited as the foam promoter. Patent Document 3 discloses a preservative for hand towels or wet tissues containing a glycerin fatty acid ester and a quaternary ammonium salt.
下記の特許文献4から特許文献6には水溶液組成物が含侵された清拭シート等が開示されている。
下記特許文献4には、不織布シートに洗浄剤を含浸させた乳幼児尻拭き用清拭シートが開示されている。該洗浄剤中の精製水濃度は、99.80~99.90重量%の範囲であり、該洗浄剤中には殺菌防腐剤としてベンザルコニウムクロリドと、ブチルカルバミン酸ヨウ化プロピニル、及びプロピレングリコール又は1,3-ブチレングリコールが含有されている。また、このような清拭シートは、肌への刺激性を抑制できる、と記載されている。
Patent documents 4 to 6 below disclose cleaning sheets and the like impregnated with aqueous solution compositions.
Patent Document 4 discloses a baby wipe sheet for wiping the bottom of infants, in which a nonwoven fabric sheet is impregnated with a cleaning agent. The purified water concentration in the cleaning agent is in the range of 99.80 to 99.90% by weight, and the cleaning agent contains benzalkonium chloride, iodide propynyl butylcarbamate, and propylene glycol or 1,3-butylene glycol as antiseptics and preservatives. It is also stated that such a wipe sheet can suppress skin irritation.
下記特許文献5には、ポリアミノプロピルビグアニドと第四級アンモニウム塩との混合物、安息香酸ナトリウム、クエン酸、エチレンジアミン四酢酸二ナトリウム、及び非イオン性界面活性剤を含み、かつ、そのpHが3.5~4.5である、繊維シート含浸用の水溶性組成物と、該水溶性組成物が含浸された繊維シートが開示されている。下記特許文献6には、乳酸、クエン酸若しくはこれらの酸の塩、第四級アンモニウム塩型界面活性剤、及び水、を含有するとともにエタノールを含有せず、且つ25℃におけるpHが3.0以上6.0未満の液剤が基材シートに含浸されたウェットシート、が開示されている。 Patent Document 5 discloses a water-soluble composition for impregnating fiber sheets, comprising a mixture of polyaminopropyl biguanide and a quaternary ammonium salt, sodium benzoate, citric acid, disodium ethylenediaminetetraacetate, and a nonionic surfactant, with a pH of 3.5 to 4.5, and a fiber sheet impregnated with this water-soluble composition. Patent Document 6 discloses a wet sheet impregnated with a base sheet containing a liquid formulation comprising lactic acid, citric acid or salts thereof, a quaternary ammonium salt-type surfactant, and water, but without ethanol, and with a pH of 3.0 or higher and less than 6.0 at 25°C.
上記特許文献1に開示された皮膚外用剤は、クリーム、化粧水、乳液等における添加剤の成分濃度が高い溶液中に、抗菌・防腐効果を発揮させる目的で配合されるので、皮膚外用剤中の抗菌・防腐剤を比較的多量に含有させる必要がある。上記特許文献2に開示された発泡抗菌性皮膚洗剤において、カプリン酸グリセリルは、ポリエチレングリコール(PEG)8000等の泡構造強化剤と共に、洗浄の間の充分な泡体積、高密度で安定な泡構造を提供するために泡促進剤として配合されている。また、該皮膚洗剤は、処方例において、純水以外の添加剤成分が約15~20重量%と多量に配合されている。 The topical skin preparations disclosed in Patent Document 1 are formulated to exert antibacterial and preservative effects in solutions with high concentrations of additive components, such as creams, lotions, and emulsions. Therefore, it is necessary to include a relatively large amount of antibacterial and preservative agents in the topical skin preparations. In the foaming antibacterial skin detergent disclosed in Patent Document 2, glyceryl caprate is included as a foam enhancer, along with foam structure strengthening agents such as polyethylene glycol (PEG) 8000, to provide sufficient foam volume and a high-density, stable foam structure during washing. Furthermore, in the formulation examples of this skin detergent, additive components other than pure water are included in large quantities, approximately 15-20% by weight.
上記特許文献3の実施例には、保存剤の成分がカプリン酸グリセリルのみである場合には抗菌性が不十分であることが示唆されているので、開示された保存剤中で抗菌剤として作用しているのは主に、ベンザルコニウムクロリド等の第4級アンモニウム塩であると想定される。しかし、抗菌剤がベンザルコニウムクロリドのみではpHが弱酸性域では抗菌性が低下し、また、抗菌剤が実質的に1成分のときには該抗菌剤に抵抗性のある菌種の存在等により充分な抗菌効果を発揮できなくなるおそれがある。上記特許文献4に開示された清拭シートにおいて、含浸される洗浄剤中に殺菌防腐剤としてブチルカルバミン酸ヨウ化プロピニルが含有されているが、該成分が含まれない清拭シートが望まれている。また、該清拭シートにおいて、防カビ性の向上も更に望まれる。 The examples in Patent Document 3 suggest that the antibacterial activity is insufficient when the preservative component is only glyceryl caprate. Therefore, it is assumed that the antibacterial agent in the disclosed preservative is mainly a quaternary ammonium salt such as benzalkonium chloride. However, if the antibacterial agent is only benzalkonium chloride, the antibacterial activity decreases in the weakly acidic pH range, and if the antibacterial agent is substantially a single component, there is a risk that it will not exhibit sufficient antibacterial effect due to the presence of bacterial species resistant to that antibacterial agent. In the cleaning sheet disclosed in Patent Document 4, propynyl iodide butylcarbamate is contained as a bactericidal preservative in the impregnated cleaning agent, but a cleaning sheet that does not contain this component is desired. Furthermore, improved mold resistance is also desired in such a cleaning sheet.
上記特許文献5に開示の繊維シート含浸用の水溶性組成物には、殺菌防腐剤として安息香酸ナトリウムが添加されている。安息香酸ナトリウムは弱酸性域で抗菌性を効果的に発揮するので、水溶性組成物のpHを調整するために、複数のpH調整剤が添加されている。更に、皮膚への刺激を低減するために、非イオン性界面活性剤が添加されているので、添加剤成分の種類が多くなっている。上記特許文献6に開示のウェットシートに含侵する液剤には、第四級アンモニウム塩型界面活性剤に対して、3~10倍重量の乳酸、クエン酸等の配合例が記載されている。従って、液剤中の精製水の濃度が相対的に低くなり、該文献には精製水濃度は97.0~99.7質量%が好ましいと記載されている。また、該液剤には、除菌剤として上記乳酸、第四級アンモニウム塩型界面活性剤等の配合が記載されて、抗菌性について評価されているが、防カビ性の評価については記載されていない。 The water-soluble composition for impregnating fiber sheets disclosed in Patent Document 5 contains sodium benzoate as a bactericidal and preservative agent. Since sodium benzoate effectively exhibits antibacterial properties in a weakly acidic range, multiple pH adjusters are added to adjust the pH of the water-soluble composition. Furthermore, nonionic surfactants are added to reduce skin irritation, resulting in a large number of additive components. Patent Document 6 discloses a liquid formulation for impregnating wet wipes, describing a blend of lactic acid, citric acid, etc., in amounts of 3 to 10 times the weight of a quaternary ammonium salt type surfactant. Therefore, the concentration of purified water in the liquid formulation becomes relatively low, and the document states that a purified water concentration of 97.0 to 99.7% by mass is preferable. While the liquid formulation describes the blending of lactic acid, quaternary ammonium salt type surfactant, etc., as disinfectants and evaluates their antibacterial properties, the evaluation of their antifungal properties is not described.
清拭シートに含侵される水系組成物の抗菌性と防カビ性の双方を向上するために、複数の保存性向上剤を配合すると、一般に精製水濃度を高濃度に維持することが困難になる問題点がある。また、清拭シートの皮膚刺激性を低減するために、精製水濃度を高濃度に維持してpHを弱酸性域に調整することが望ましいが、この場合、一般的にはpH調整剤の添加が必要となり、またpHが弱酸性域では抗菌剤の種類により抗菌性が低下する問題点がある。
本発明は、かかる事情に鑑みてなされたもので、基材シートに含侵させる水系組成物に特定の保存性向上剤を選択して配合することにより抗菌性と防カビ性を向上すると共に、精製水を高濃度に維持し、かつpHを弱酸性に維持可能して、肌のデリケートな乳幼児や肌の弱い老人にも好適に使用することができる、清拭シートを提供することを目的とする。
When multiple preservatives are added to improve both the antibacterial and antifungal properties of the aqueous composition impregnated into the cleaning sheets, it generally becomes difficult to maintain a high concentration of purified water. Furthermore, to reduce the skin irritation of the cleaning sheets, it is desirable to maintain a high concentration of purified water and adjust the pH to a weakly acidic range. However, in this case, the addition of a pH adjuster is generally necessary, and there is a problem that the antibacterial properties decrease depending on the type of antibacterial agent at a weakly acidic pH.
The present invention has been made in view of these circumstances, and aims to provide a cleansing sheet that can be suitably used on infants with delicate skin and elderly people with sensitive skin by selectively incorporating a specific preservative enhancer into an aqueous composition impregnated into a base sheet, thereby improving antibacterial and antifungal properties, and by maintaining a high concentration of purified water and maintaining a slightly acidic pH.
本発明者らは、上記従来技術に鑑みて、清拭シート含侵用の水系組成物に保存性を向上するために、抗菌剤として、pHの影響を受ける可能性のあるベンザルコニウムクロリドと、pHの影響を受ける可能性の少ないポリアミノプロピルビグアニド塩酸塩とを併用すると共に、防カビ剤としてカプリン酸グリセリルを含有させ、また該カプリン酸グリセリルの配合に基づき可溶化剤を含有させ、更に、皮膚に対する刺激性を抑制するために、該水系組成物中の精製水濃度を高濃度に維持すると共に、ベンザルコニウムクロリドとポリアミノプロピルビグアニド塩酸塩をそれぞれ所定量含有させて水系組成物のpHを弱酸性域に保つことを可能とすることにより、
保存安定性に優れ、更に皮膚への刺激を低減できる清拭シートが得られることを見出し、本発明を完成させるに至った。
即ち、本発明は以下の(1)~(8)に記載する発明を要旨とする。
In view of the above-mentioned prior art, the present inventors have, in order to improve the shelf life of an aqueous composition for impregnation of a cleaning sheet, used a combination of benzalkonium chloride, which may be affected by pH, and polyaminopropyl biguanide hydrochloride, which is less affected by pH, as antibacterial agents, and also included glyceryl caprate as an antifungal agent, and a solubilizer based on the formulation of glyceryl caprate, and further, in order to suppress skin irritation, the concentration of purified water in the aqueous composition is maintained at a high concentration, and predetermined amounts of benzalkonium chloride and polyaminopropyl biguanide hydrochloride are included, respectively, to enable the pH of the aqueous composition to be kept in the weakly acidic range,
We discovered that it is possible to obtain a cleansing sheet that has excellent storage stability and further reduces skin irritation, which led to the completion of the present invention.
In other words, the gist of the present invention is the invention described in (1) to (8) below.
(1)織布又は不織布からなる基材シートに保存性向上剤と可溶化剤を含む水系組成物が含浸されてなる清拭シートであって、
前記水系組成物は、精製水中に、保存性向上剤として、抗菌剤成分であるベンザルコニウムクロリドとポリアミノプロピルビグアニド塩酸塩、及び防カビ剤成分であるカプリン酸グリセリル、並びに可溶化剤として、カプリン酸グリセリルを可溶化させる溶剤が含まれていて、
前記水系組成物における、ベンザルコニウムクロリドの含有量(b1)が0.030質量%以上0.050質量%以下、ポリアミノプロピルビグアニド塩酸塩の含有量(b2)が0.025質量%以上0.070質量%以下、カプリン酸グリセリルの含有量(c1)が0.003質量%以上0.050質量%以下、であり、
前記清拭シートにおける水相部のpHが弱酸性であり、
更に、前記水系組成物における、精製水の濃度が99.85質量%以上99.92質量%以下である、ことを特徴とする清拭シート。
(1) A cleaning sheet comprising a base sheet made of woven or nonwoven fabric impregnated with an aqueous composition containing a preservative enhancer and a solubilizer,
The aforementioned aqueous composition contains, in purified water, benzalkonium chloride and polyaminopropyl biguanide hydrochloride as preservatives, which are antimicrobial components, and glyceryl caprate as an antifungal component, and a solvent that solubilizes glyceryl caprate as a solubilizer.
In the aqueous composition, the content of benzalkonium chloride (b1) is 0.030% by mass or more and 0.050% by mass or less, the content of polyaminopropyl biguanide hydrochloride (b2) is 0.025% by mass or more and 0.070% by mass or less, and the content of glyceryl caprate (c1) is 0.003% by mass or more and 0.050% by mass or less.
The pH of the aqueous phase in the aforementioned cleaning sheet is weakly acidic.
Furthermore, the cleaning sheet is characterized in that the concentration of purified water in the aqueous composition is 99.85% by mass or more and 99.92% by mass or less.
(2)前記水系組成物における、ベンザルコニウムクロリドの含有量(b1)とポリアミノプロピルビグアニド塩酸塩の含有量(b2)の合計量(b1+b2)が0.060質量%以上0.105質量%以下であり、かつ、ポリアミノプロピルビグアニド塩酸塩の含有量(b2)とベンザルコニウムクロリドの含有量(b1)との質量比(b2/b1)が0.625以上2.00以下である、前記(1)に記載の清拭シート。
(3)前記水系組成物における、防カビ剤成分であるカプリン酸グリセリルの含有量(c1)と、抗菌剤成分であるベンザルコニウムクロリドの含有量(b1)とポリアミノプロピルビグアニド塩酸塩の含有量(b2)の合計量(b1+b2)との質量比(c1/(b1+b2))が、0.035以上0.833以下である、前記(1)又は(2)に記載の清拭シート。
(2) The cleaning sheet according to (1), wherein the total amount (b1 + b2) of the content of benzalkonium chloride (b1) and the content of polyaminopropyl biguanide hydrochloride (b2) in the aqueous composition is 0.060% by mass or more and 0.105% by mass or less, and the mass ratio (b2/b1) of the content of polyaminopropyl biguanide hydrochloride (b2) to the content of benzalkonium chloride (b1) is 0.625 or more and 2.00 or less.
(3) The cleaning sheet according to (1) or (2) above, wherein the mass ratio (c1/(b1+b2)) of the content of glyceryl caprate, which is an antifungal agent component, in the aqueous composition to the total amount (b1+b2) of the content of benzalkonium chloride, which is an antibacterial agent component, and the content of polyaminopropyl biguanide hydrochloride, which is an antibacterial agent component, is 0.035 or more and 0.833 or less.
(4)前記水系組成物における、カプリン酸グリセリルを可溶化させる溶剤の含有量(d1)と、防カビ剤成分であるカプリン酸グリセリルの含有量(c1)との質量比(d1/c1)が0.60以上2.14以下である、前記(1)から(3)のいずれかに記載の清拭シート。
(5)前記水系組成物における、カプリン酸グリセリルを可溶化させる溶剤が常温の15~25℃において液状であり、かつOH末端基を有するポリエーテルである、
前記(1)から(4)のいずれかに記載の清拭シート。
(4) The cleaning sheet according to any one of (1) to (3), wherein the mass ratio (d1/c1) of the content of the solvent for solubilizing glyceryl caprate (d1) to the content of the antifungal agent component glyceryl caprate (c1) in the aqueous composition is 0.60 or more and 2.14 or less.
(5) The solvent in the aqueous composition that solubilizes glyceryl caprate is a polyether that is liquid at room temperature of 15 to 25°C and has OH-terminated groups.
A cleaning sheet as described in any of (1) to (4) above.
(6)前記水系組成物における、カプリン酸グリセリルを可溶化させる溶剤が数平均分子量100以上600以下のポリエチレングリコールである、前記(1)から(5)のいずれかに記載の清拭シート。
(7)前記清拭シートにおける水相部の25℃でのpHが6.1以上6.6以下である、前記(1)から(6)のいずれかに記載の清拭シート。
(8)前記清拭シートが、乳幼児の尻拭き用、又は病人、老人、もしくは乳幼児の身体清拭用の清拭シートである、前記(1)から(7)のいずれかに記載の清拭シート。
(6) The cleaning sheet according to any one of (1) to (5), wherein the solvent for solubilizing glyceryl caprate in the aqueous composition is polyethylene glycol having a number average molecular weight of 100 or more and 600 or less.
(7) The cleaning sheet according to any one of (1) to (6), wherein the pH of the aqueous phase portion of the cleaning sheet at 25°C is 6.1 or more and 6.6 or less.
(8) The cleansing sheet according to any one of (1) to (7) above, wherein the cleansing sheet is for wiping the bottom of an infant or for wiping the body of a sick person, an elderly person, or an infant.
本発明の清拭シートは、織布又は不織布からなる基材シートに水系組成物が含侵されており、該水系組成物には、保存性向上剤として、抗菌剤成分であるベンザルコニウムクロリドとポリアミノプロピルビグアニド塩酸塩、及び防カビ剤成分であるカプリン酸グリセリルがそれぞれ特定量含有されている。それ故、本発明の清拭シートは、抗菌性と防カビ性の双方が向上されることにより、保存安定性が高められている。
また、本発明の清拭シートにおいて、含浸される水系組成物中の保存性向上剤と可溶化剤の含有量を極力少なくして精製水濃度が高められており、更に、ベンザルコニウムクロリドとポリアミノプロピルビグアニド塩酸塩をそれぞれ所定量含有されていて、pHが弱酸性域に保たれることにより、清拭シートによる皮膚への刺激が低減されている。
The cleaning sheet of the present invention comprises a base sheet made of woven or nonwoven fabric impregnated with an aqueous composition, the aqueous composition containing specific amounts of benzalkonium chloride and polyaminopropyl biguanide hydrochloride, which are antibacterial agents, and glyceryl caprate, which is an antifungal agent, as preservatives. Therefore, the cleaning sheet of the present invention has improved storage stability by enhancing both antibacterial and antifungal properties.
Furthermore, in the present invention, the content of preservatives and solubilizers in the impregnated aqueous composition is kept to a minimum, thereby increasing the concentration of purified water. In addition, predetermined amounts of benzalkonium chloride and polyaminopropyl biguanide hydrochloride are contained, and the pH is maintained in the weakly acidic range, thereby reducing skin irritation caused by the cleansing sheet.
以下に、本発明の清拭シートについて説明する。
本発明の清拭シートは、織布又は不織布からなる基材シートに保存性向上剤と可溶化剤を含む水系組成物が含浸されてなる清拭シートであって、
前記水系組成物は、精製水中に、保存性向上剤として、抗菌剤成分であるベンザルコニウムクロリドとポリアミノプロピルビグアニド塩酸塩、及び防カビ剤成分であるカプリン酸グリセリル、
並びに可溶化剤として、カプリン酸グリセリルを可溶化させる溶剤が含まれていて、
前記水系組成物における、ベンザルコニウムクロリドの含有量(b1)が0.030質量%以上0.050質量%以下、ポリアミノプロピルビグアニド塩酸塩の含有量(b2)が0.025質量%以上0.070質量%以下、カプリン酸グリセリルの含有量(c1)が0.003質量%以上0.050質量%以下、であり、前記清拭シートにおける水相部のpHが弱酸性であり、更に、前記水系組成物における、精製水の濃度が99.85質量%以上99.92質量%以下である、ことを特徴とする。
本発明の清拭シートを(1)水系組成物、(2)基材シート、(3)清拭シート、に分けて、以下に具体的に説明する。
The cleaning sheet of the present invention will be described below.
The present invention provides a cleaning sheet comprising a base sheet made of woven or nonwoven fabric impregnated with an aqueous composition containing a preservative enhancer and a solubilizer,
The aforementioned aqueous composition contains, in purified water, benzalkonium chloride and polyaminopropyl biguanide hydrochloride as preservatives, and glyceryl caprate as an antifungal agent.
Furthermore, it contains a solvent that solubilizes glyceryl caprate as a solubilizing agent.
The aqueous composition is characterized in that the content of benzalkonium chloride (b1) is 0.030% by mass or more and 0.050% by mass or less, the content of polyaminopropyl biguanide hydrochloride (b2) is 0.025% by mass or more and 0.070% by mass or less, and the content of glyceryl caprate (c1) is 0.003% by mass or more and 0.050% by mass or less, the pH of the aqueous phase of the cleaning sheet is weakly acidic, and furthermore, the concentration of purified water in the aqueous composition is 99.85% by mass or more and 99.92% by mass or less.
The cleaning sheet of the present invention will be described in detail below, divided into (1) an aqueous composition, (2) a base sheet, and (3) a cleaning sheet.
(1)水系組成物
(1-1)精製水
水系組成物に使用される精製水は、例えば、水道水等の常水を用いて、必要に応じて前処理後、イオン交換、蒸留、濾過等から選択される1種又は2種以上の手段の組み合わせにより精製するのが好ましく、更に紫外線殺菌装置等により殺菌処理することがより好ましい。水の殺菌処理としては、紫外線殺菌、熱殺菌、オゾン水殺菌、塩素系殺菌等が挙げられるが、大型の設備や大熱量を必要とせず、水質に影響を与えない紫外線殺菌が好ましい。上記手段により得られた精製水は、精製後、又は精製と殺菌処理された後の電気伝導度が25℃で1μS/cm以下であることが好ましい。電気伝導度は、水溶液における電気の伝わり易さを示すもので、溶液の電気抵抗の逆数であり、イオン性物質の不純物含有量が増えるほど電気伝導度は増加する。
(1) Aqueous Composition (1-1) Purified Water The purified water used in the aqueous composition is preferably purified by using ordinary water such as tap water, and after pretreatment as necessary, by one or more methods selected from ion exchange, distillation, filtration, etc., and more preferably by sterilization treatment using an ultraviolet sterilization device. Examples of water sterilization treatments include ultraviolet sterilization, thermal sterilization, ozone water sterilization, and chlorine-based sterilization, but ultraviolet sterilization is preferred as it does not require large equipment or a large amount of heat and does not affect water quality. The purified water obtained by the above means preferably has an electrical conductivity of 1 μS/cm or less at 25°C after purification, or after purification and sterilization treatment. Electrical conductivity indicates how easily electricity is conducted in an aqueous solution, and is the reciprocal of the electrical resistance of the solution. Electrical conductivity increases as the amount of ionic impurities increases.
(1-2)保存性向上剤
清拭シートを乳幼児の尻拭き、又は病人、老人、乳幼児の身体清拭用等に使用する場合に皮膚への刺激を少なくするためには、清拭シートに含浸させる水系組成物中の精製水の濃度が高い方が好ましい。一方、精製水濃度が高い水系組成物ほど保存中に細菌やカビが発生し易くなるので、保存上の問題が生ずることになる。従って、水系組成物中の保存性向上剤の濃度を極力低くして皮膚への刺激性を少なくし、かつ長期間の保存を可能にするためには、保存性向上剤の選択とその含有量の決定は極めて重要である。
(1-2) Preservatives When using cleansing sheets for wiping the bottoms of infants or for wiping the bodies of sick people, the elderly, or infants, it is preferable to have a higher concentration of purified water in the aqueous composition impregnated into the cleansing sheets in order to reduce skin irritation. On the other hand, aqueous compositions with a higher concentration of purified water are more prone to bacterial and mold growth during storage, which can lead to storage problems. Therefore, in order to minimize skin irritation by keeping the concentration of preservatives in the aqueous composition as low as possible and to enable long-term storage, the selection of preservatives and the determination of their content are extremely important.
保存性向上剤として、種々の抗菌剤等が知られているが、これまで広く使用されてきた前記パラベンの使用を避ける傾向があることから、本発明においては、保存性向上剤として、いずれも化粧品に用いられている、抗菌剤成分であるベンザルコニウムクロリドとポリアミノプロピルビグアニド塩酸塩、及び防カビ剤成分であるカプリン酸グリセリルが使用される。
本発明において、上記「抗菌剤成分である」とは、主として抗菌性を発揮する成分であることを意味し、上記「防カビ剤成分である」とは、主として防カビ性を発揮する成分であることを意味する。
Various antibacterial agents are known as preservatives, but there is a tendency to avoid the use of parabens, which have been widely used until now. Therefore, in the present invention, benzalkonium chloride and polyaminopropyl biguanide hydrochloride, which are antibacterial components, and glyceryl caprate, which is an antifungal component, are used as preservatives, all of which are used in cosmetics.
In the present invention, "antibacterial agent component" means a component that primarily exhibits antibacterial properties, and "fungal agent component" means a component that primarily exhibits fungicidal properties.
抗菌剤成分として、ベンザルコニウムクロリドは、化粧品に配合可能な防腐剤リスト(ポジティブリスト)に収載されているが、その含有量は減少させることが望ましい。抗菌剤成分がベンザルコニウムクロリドのみからなる成分では、pHが弱酸性域で抗菌性が低下するおそれがあり、また該抗菌剤に抵抗性のある菌種の存在等により抗菌効果を充分に発揮できなくなるおそれがある。従って、抗菌剤成分としては少なくとも2成分の使用が好ましいことから、本発明では、抗菌剤成分として、ベンザルコニウムクロリドと、pH変化により抗菌性の低下が少ないポリアミノプロピルビグアニド塩酸塩を併用する。該併用により抗菌性を向上できるほか、ベンザルコニウムクロリドとポリアミノプロピルビグアニド塩酸塩の含有割合を調整することにより、水系組成物のpHを皮膚刺激性の少ない弱酸性に調整することも可能になる。 While benzalkonium chloride is listed as an antibacterial agent in the list of preservatives permissible in cosmetics (positive list), it is desirable to reduce its content. In formulations consisting solely of benzalkonium chloride, the antibacterial activity may decrease in the weakly acidic pH range, and the antibacterial effect may not be fully realized due to the presence of bacterial species resistant to the agent. Therefore, since the use of at least two antibacterial agents is preferable, this invention uses benzalkonium chloride in combination with polyaminopropyl biguanide hydrochloride, which exhibits less reduction in antibacterial activity with pH changes. This combination improves antibacterial activity, and by adjusting the ratio of benzalkonium chloride and polyaminopropyl biguanide hydrochloride, the pH of the aqueous composition can be adjusted to a weakly acidic pH with low skin irritation.
保存性向上剤として、抗菌剤成分であるベンザルコニウムクロリドとポリアミノプロピルビグアニド塩酸塩の2種のみを選択する場合には充分な防カビ性が期待できないことから、更に防カビ剤成分であるカプリン酸グリセリルを併用することにより、抗菌性に加えて防カビ性も向上させることが可能になる。尚、水系組成物中にカプリン酸グリセリルを含有させる場合には、該成分は水溶液への溶解性が低いことから、可溶化剤として、カプリン酸グリセリルを可溶化させる溶剤を含有させる必要がある。 When selecting only benzalkonium chloride and polyaminopropyl biguanide hydrochloride, which are antibacterial agents, as preservatives, sufficient antifungal properties cannot be expected. Therefore, by combining them with glyceryl caprate, an antifungal agent, it is possible to improve both antibacterial and antifungal properties. Furthermore, when including glyceryl caprate in an aqueous composition, since this component has low solubility in aqueous solutions, it is necessary to include a solvent that solubilizes glyceryl caprate as a solubilizing agent.
抗菌剤成分として、ベンザルコニウムクロリドとポリアミノプロピルビグアニド塩酸塩を併用することにより、ベンザルコニウムクロリドの含有量を減少させることも可能になる。このように、水系組成物中に少量のベンザルコニウムクロリドとポリアミノプロピルビグアニド塩酸塩を含有させて抗菌性を向上させ、更に少量のカプリン酸グリセリルを含有させて防カビ性を向上させることにより、保存安定性を向上させると共に水系組成物のpHを弱酸性に調整して、人体の皮膚への刺激性の低い水系組成物が得られることは本発明の特徴である。 By using benzalkonium chloride and polyaminopropyl biguanide hydrochloride in combination as antibacterial agents, it is possible to reduce the amount of benzalkonium chloride. Thus, by incorporating small amounts of benzalkonium chloride and polyaminopropyl biguanide hydrochloride into the aqueous composition to improve its antibacterial properties, and further incorporating small amounts of glyceryl caprate to improve its antifungal properties, the present invention provides an aqueous composition with improved storage stability and a slightly acidic pH, resulting in a composition with low irritation to human skin.
以下に水系組成物に含有される、保存性向上剤と可溶化剤について説明する。
(1-3)保存性向上剤中の各成分
(i)ベンザルコニウムクロリド
化粧品分野で抗菌剤成分として広く使用されている、ベンザルコニウムクロリドは、化学名がアルキルジメチルベンジルアンモニウムクロリドであり、下記の化学式(1)で示される。
[RC6H5CH2N+(CH3)2]Cl-・・・・・・・・・・・(1)
上記化学式(1)で示されるベンザルコニウムクロリドは、アルキル基(R)の一部又はすべてが炭素数8から18(C8H17~C18H37)のアルキル基からなる、混合物である。
The preservatives and solubilizers contained in the aqueous composition are described below.
(1-3) Components in preservatives (i) Benzalkonium chloride Benzalkonium chloride, which is widely used as an antibacterial agent in the cosmetics field, has the chemical name alkyldimethylbenzylammonium chloride and is represented by the following chemical formula (1).
[RC 6 H 5 CH 2 N + (CH 3 ) 2 ]Cl -・・・・・・・・・・・・(1)
The benzalkonium chloride represented by the above chemical formula (1) is a mixture in which some or all of the alkyl groups (R) consist of alkyl groups having 8 to 18 carbon atoms ( C8H17 to C18H37 ).
ベンザルコニウムクロリドは、その希釈水溶液は弱アルカリ性であり、弱アルカリ性で優れた殺菌性を発揮するが、pHが中性ないし弱酸性の水溶液に調整されると殺菌性が低下することが知られている。例えば、市販のベンザルコニウムクロリドについて、石炭酸係数(石炭酸を基準にして殺菌力が石炭酸の何倍であるかを示す数値)を用いてpHと殺菌性の関係を示すと、常温付近においてpH7での殺菌力はpH9、11での殺菌力のそれぞれ約0.86、0.54倍に低下し、pH5での殺菌力はpH9、11での殺菌力のそれぞれ約0.78、0.49倍に低下することが知られている。 Benzalkonium chloride, in its diluted aqueous solution, is weakly alkaline and exhibits excellent bactericidal properties in a weakly alkaline environment. However, it is known that its bactericidal properties decrease when the pH is adjusted to a neutral or weakly acidic aqueous solution. For example, using the carbolic coefficient (a numerical value indicating how many times more bactericidal a substance is compared to carbolic acid) for commercially available benzalkonium chloride, the relationship between pH and bactericidal properties is known to decrease at around room temperature: at pH 7, the bactericidal properties at pH 9 and 11 are approximately 0.86 and 0.54 times lower than at pH 9 and 11, respectively; and at pH 5, the bactericidal properties are approximately 0.78 and 0.49 times lower than at pH 9 and 11, respectively.
(ii)ポリアミノプロピルビグアニド塩酸塩
ポリアミノプロピルビグアニドは下記の化学式(2)で示される、分子中に多数の陽電荷をもつカチオン性高分子である。
[-NH-C(=NH)-NH-C(=NH) -NH-(CH2)3-]n ・・・・・(2)
ポリアミノプロピルビグアニドは、塩酸塩等の無機酸塩、及びフマル酸塩等の有機酸塩等が存在することが知られている。抗菌剤に使用する場合、ポリアミノプロピルビグアニド、及びポリアミノプロピルビグアニド無機酸塩等として使用することが可能であるが、本発明においては、ポリアミノプロピルビグアニド塩酸塩が好ましい。
(ii) Polyaminopropyl biguanide hydrochloride Polyaminopropyl biguanide is a cationic polymer with numerous positive charges in its molecule, represented by the following chemical formula (2).
[-NH-C(=NH)-NH-C(=NH) -NH-(CH 2 ) 3 -] n ...(2)
Polyaminopropyl biguanide is known to exist in the form of inorganic salts such as hydrochloride and organic salts such as fumarate. When used as an antibacterial agent, it can be used as polyaminopropyl biguanide or its inorganic salt, but in the present invention, polyaminopropyl biguanide hydrochloride is preferred.
ポリアミノプロピルビグアニド塩酸塩は、水への溶解度が高く、広い温度範囲、pH範囲でも抗菌活性は安定している。また、ポリアミノプロピルビグアニド塩酸塩は、大腸菌、黄色ブドウ球菌、緑膿菌等対して抗菌性があることから、細菌に対しては広い抗菌スペクトルを有しているが、カンジタ、黒コウジカビ等の真菌に対しては防カビ効果が比較的低いことが知られている。
上記化学式(2)において、ポリアミノプロピルビグアニドの重合度nは5~50が好ましく、10~20がより好ましい。また、ポリアミノプロピルビグアニドの重量平均分子量は、800~8000が好ましく、2000~3000がより好ましい。尚、重量平均分子量(Mw)は、公知の測定法により求めることができる。
Polyaminopropyl biguanide hydrochloride has high solubility in water and maintains stable antibacterial activity over a wide temperature and pH range. Furthermore, while polyaminopropyl biguanide hydrochloride exhibits antibacterial activity against bacteria such as E. coli, Staphylococcus aureus, and Pseudomonas aeruginosa, thus possessing a broad antibacterial spectrum against bacteria, it is known to have relatively low antifungal activity against fungi such as Candida and Aspergillus niger.
In the above chemical formula (2), the degree of polymerization n of polyaminopropyl biguanide is preferably 5 to 50, and more preferably 10 to 20. Furthermore, the weight-average molecular weight of polyaminopropyl biguanide is preferably 800 to 8000, and more preferably 2000 to 3000. The weight-average molecular weight (Mw) can be determined by known measurement methods.
(iii)カプリン酸グリセリル
カプリン酸グリセリルは、炭素数10の飽和脂肪酸であるカプリン酸とグリセリンのモノエステルであり、下記の化学式(3)と式(4)で示される、2種の異性体が存在する。
CH2OH-CHOH-CH2-O-CO-(CH2)8CH3 ・・・・(3)
CH2OH-CH-O-(CO-(CH2)8CH3)-CH2OH ・・(4)
炭素数8、10、12の脂肪酸とグリセリンのモノエステルがそれぞれ知られている。これらの中で、他の抗菌剤成分との併用による抗菌性と防カビ性の相乗効果、可溶化剤を使用した水溶液への溶解性、低濃度における防カビ性の効果、入手の容易性等を考慮すると、防カビ剤成分として、炭素数10のカプリン酸とグリセリンのモノエステルであるカプリン酸グリセリルが好ましい。
(iii) Glyceryl Caprate Glyceryl caprate is a monoester of capric acid, a saturated fatty acid with 10 carbon atoms, and glycerol, and has two isomers, represented by the following chemical formulas (3) and (4).
CH2OH -CHOH- CH2 -O-CO-( CH2 ) 8CH3 ...( 3 )
CH2OH -CH-O-(CO-( CH2 ) 8CH3 ) -CH2OH ...(4)
Monoesters of fatty acids with 8, 10, and 12 carbon atoms and glycerin are known. Among these, considering the synergistic effect of antibacterial and antifungal properties when used in combination with other antibacterial components, solubility in aqueous solutions using solubilizers, antifungal effect at low concentrations, and ease of availability, glyceryl caprate, which is a monoester of capric acid with 10 carbon atoms and glycerin, is preferred as the antifungal component.
カプリン酸グリセリルは一般に天然由来の大豆油などの植物油性脂肪酸をグリセリンでエステル化して、合成される非イオン界面活性剤である。カプリン酸グリセリルは、常温で固体であり、また親油性であるので水溶液への溶解度は、25℃において126mg/リットルである。カプリン酸グリセリルは、化粧品の分野で、主に油性製品や乳化系製品に使用されてきたが可溶化剤と併用することで水系製品にも配合することが可能になる。 Glyceryl caprate is a nonionic surfactant generally synthesized by esterifying naturally derived vegetable oil fatty acids, such as soybean oil, with glycerin. Glyceryl caprate is solid at room temperature and is lipophilic, so its solubility in aqueous solutions is 126 mg/liter at 25°C. While glyceryl caprate has primarily been used in oily and emulsified cosmetics, it can also be incorporated into water-based products when used in combination with a solubilizer.
(1-4)保存性向上剤の各成分の含有量
本発明の清拭シートの保存安定性を向上して、皮膚刺激性を減少するためには、清拭シートに含侵される水系組成物中の保存性向上剤の各成分の配合範囲を下記の通りにする必要がある。
(1-4) Content of each component of the preservative enhancer In order to improve the storage stability of the cleaning sheet of the present invention and reduce skin irritation, the blending range of each component of the preservative enhancer in the aqueous composition impregnated into the cleaning sheet must be as follows.
抗菌剤成分であるベンザルコニウムクロリドの含有量(b1)は、0.030質量%以上0.050質量%以下であり、0.035質量%以上0.050質量%以下が好ましい。抗菌剤成分であるポリアミノプロピルビグアニド塩酸塩の含有量(b2)は、0.025質量%以上0.070質量%以下であり、0.035質量%以上0.070質量%以下が好ましい。防カビ剤成分であるカプリン酸グリセリルの含有量(c1)は、0.003質量%以上0.050質量%以下であり、0.0035質量%以上0.050質量%以下が好ましい。
前記水系組成物中において、ベンザルコニウムクロリドとポリアミノプロピルビグアニド塩酸塩、カプリン酸グリセリルは前記含有量において、抗菌性、防カビ性をそれぞれ有効に発揮することが可能である。
The content of benzalkonium chloride, an antibacterial agent component (b1), is 0.030% by mass or more and 0.050% by mass or less, preferably 0.035% by mass or more and 0.050% by mass or less. The content of polyaminopropyl biguanide hydrochloride, an antibacterial agent component (b2), is 0.025% by mass or more and 0.070% by mass or less, preferably 0.035% by mass or more and 0.070% by mass or less. The content of glyceryl caprate, an antifungal agent component (c1), is 0.003% by mass or more and 0.050% by mass or less, preferably 0.0035% by mass or more and 0.050% by mass or less.
In the aqueous composition, benzalkonium chloride, polyaminopropyl biguanide hydrochloride, and glyceryl caprate can effectively exhibit antibacterial and antifungal properties, respectively, at the aforementioned concentrations.
(1-5)保存性向上剤の各成分の含有割合
本発明の清拭シートの保存安定性と皮膚刺激性の低減化を更に考慮すると、該清拭シートに含侵される水系組成物中での保存性向上剤の各成分の含有割合を以下の通りにすることが好ましい。
抗菌性を考慮すると、ベンザルコニウムクロリドの含有量(b1)とポリアミノプロピルビグアニド塩酸塩の含有量(b2)の合計量(b1+b2)は0.06質量%以上0.105質量%以下が好ましく、皮膚刺激性を減少するために水系組成物のpHを考慮すると、ポリアミノプロピルビグアニド塩酸塩の含有量(b2)とベンザルコニウムクロリドの含有量(b1)との質量比(b2/b1)は0.625以上2.00以下が好ましい。
(1-5) Content ratio of each component of the preservative improving agent In order to further consider the storage stability and reduction of skin irritation of the cleaning sheet of the present invention, it is preferable that the content ratio of each component of the preservative improving agent in the aqueous composition impregnated into the cleaning sheet be as follows.
Considering antibacterial properties, the total amount of benzalkonium chloride (b1) and polyaminopropyl biguanide hydrochloride (b2) (b1 + b2) is preferably 0.06% by mass or more and 0.105% by mass or less. Considering the pH of the aqueous composition to reduce skin irritation, the mass ratio of polyaminopropyl biguanide hydrochloride (b2) to benzalkonium chloride (b1) (b2/b1) is preferably 0.625 or more and 2.00 or less.
また、水系組成物の抗菌性と防カビ性の双方の向上を考慮すると、防カビ剤成分であるカプリン酸グリセリルの含有量(c1)と、抗菌剤成分であるベンザルコニウムクロリドの含有量(b1)とポリアミノプロピルビグアニド塩酸塩の含有量(b2)の合計量(b1+b2)との質量比(c1/(b1+b2))は、0.035以上0.833以下が好ましい。 Furthermore, considering the improvement of both the antibacterial and antifungal properties of the aqueous composition, the mass ratio (c1/(b1+b2)) of the content of the antifungal agent component, glyceryl caprate (c1), to the total amount (b1+b2) of the antibacterial agents, benzalkonium chloride (b1) and polyaminopropyl biguanide hydrochloride (b2), is preferably 0.035 or more and 0.833 or less.
(1-6)可溶化剤
カプリン酸グリセリルは水溶液への溶解度が上記の通り極めて低いので、水系組成物中にカプリン酸グリセリルを均一に溶解させるために、カプリン酸グリセリルを可溶化させる溶剤を含有させる必要がある。溶剤としては、カプリン酸グリセリルを水系組成物中に均一に溶解することができれば特に制限はされないが、カプリン酸グリセリルとの溶解性、水溶性、含有量、安全性等を考慮すると、常温の15~25℃において液状であり、かつOH末端基を有するポリエーテルが好ましい。このようなポリエーテルとしては、エチレンオキサイドを付加反応させて得られるポリエチレングリコールの他、エチレンオキサイドと、プロピレンオキサイド、または1,3-ブチレンオキサイド等とを付加反応させたポリエーテルが挙げることができる。これらのポリエーテルは、共にエーテル結合と末端にOH結合があるため、優れた溶媒で熱に安定でしかも多くの化学薬品に比較的不活性である。
(1-6) Solubilizers As described above, glyceryl caprate has extremely low solubility in aqueous solutions. Therefore, in order to uniformly dissolve glyceryl caprate in the aqueous composition, it is necessary to include a solvent that solubilizes glyceryl caprate. The solvent is not particularly limited as long as it can uniformly dissolve glyceryl caprate in the aqueous composition. However, considering solubility with glyceryl caprate, water solubility, content, and safety, a polyether that is liquid at room temperature (15-25°C) and has OH-terminated groups is preferred. Examples of such polyethers include polyethylene glycol obtained by the addition reaction of ethylene oxide, as well as polyethers obtained by the addition reaction of ethylene oxide with propylene oxide or 1,3-butylene oxide. Since these polyethers all have ether bonds and OH bonds at their ends, they are excellent solvents, heat stable, and relatively inert to many chemicals.
前記ポリエーテルの中でも、常温での液状と、刺激性の減少、カプリン酸グリセリルの可溶化性を考慮すると、数平均分子量が100以上600以下のポリエチレングリコールがより好ましく、数平均分子量が200以上300以下のポリエチレングリコールが更に好ましい。数平均分子量が100以上600以下のポリエチレングリコールは、蒸気圧が低く、水溶液に低濃度で溶解しているとべと付きを抑制することもできる。尚、皮膚への刺激を低減するためには、メタノール、エタノールのような低級アルコールは含有されていないことが好ましい。
水系組成物への可溶化性の維持とべた付きの防止、及び精製水濃度を高濃度に維持するために水系組成物における前記溶剤の含有量(d1)とカプリン酸グリセリルの含有量(c1)との質量比(d1/c1)は、0.60以上2.14以下が好ましい。
Among the polyethers mentioned above, polyethylene glycol with a number average molecular weight of 100 to 600 is more preferred, and polyethylene glycol with a number average molecular weight of 200 to 300 is even more preferred, considering its liquid state at room temperature, reduced irritation, and the solubilization of glyceryl caprate. Polyethylene glycol with a number average molecular weight of 100 to 600 has a low vapor pressure and can suppress stickiness when dissolved in an aqueous solution at low concentrations. Furthermore, in order to reduce skin irritation, it is preferable that the polyether does not contain lower alcohols such as methanol or ethanol.
To maintain solubilization in aqueous compositions, prevent stickiness, and maintain a high concentration of purified water, the mass ratio (d1/c1) of the solvent content (d1) to the capric acid content (c1) in the aqueous composition is preferably 0.60 or more and 2.14 or less.
(1-7)水系組成物における精製水濃度とpH値
前記水系組成物における、精製水の濃度は、99.85質量%以上99.92質量%以下である。該水系組成物は、精製水中に保存性向上剤と可溶化剤が含有されているが、上記の通りいずれの含有量を少量とすることにより、精製水を高濃度に維持できて、皮膚刺激性の低減化を図ることが可能になる。
(1-7) Purified water concentration and pH value in aqueous composition The concentration of purified water in the aqueous composition is 99.85% by mass or more and 99.92% by mass or less. The aqueous composition contains a preservative and a solubilizer in the purified water, but as described above, by keeping the amount of each small, it is possible to maintain a high concentration of purified water and reduce skin irritation.
また、乳幼児、老人や肌の弱い病人等への皮膚刺激性の低減化、後述するように皮膚表面のpHは弱酸性であること等を考慮すると、25℃における水系組成物のpHは、3.47~3.83が好ましい。尚、水系組成物のpH値は、(株)堀場製作所製、HORIBA pH METER F-21を用いて得られる測定値である。このようなpH範囲にある水系組成物は、例えば、ポリエチレンテレフタレート繊維とレーヨン繊維からなる複合繊維等から得られる不織布シートに含侵させると、得られる清拭シートにおける水相部のpHを弱酸性である6.1~6.6程度に維持することが可能になり、身体を清拭シートで拭きとる際の皮膚刺激を低減することができる。 Furthermore, considering the need to reduce skin irritation to infants, the elderly, and people with sensitive skin, and the fact that the pH of the skin surface is weakly acidic (as will be discussed later), the pH of the aqueous composition at 25°C is preferably 3.47 to 3.83. The pH value of the aqueous composition is measured using a HORIBA pH METER F-21 manufactured by HORIBA, Ltd. When an aqueous composition within this pH range is impregnated into a nonwoven fabric sheet obtained from, for example, a composite fiber consisting of polyethylene terephthalate fibers and rayon fibers, it becomes possible to maintain the pH of the aqueous phase in the resulting cleansing sheet at a weakly acidic level of approximately 6.1 to 6.6, thereby reducing skin irritation when wiping the body with the cleansing sheet.
(1-8)その他の添加剤
水系組成物中に、保存性向上剤の効果を損なわない範囲において、他の添加剤を少量含有させることも可能である。このような添加剤として、保湿作用を有するヒアルロン酸、コラーゲン等が挙げられる。
(1-8) Other Additives It is also possible to include small amounts of other additives in the aqueous composition, as long as they do not impair the effect of the preservatives. Examples of such additives include hyaluronic acid and collagen, which have moisturizing properties.
(2)基材シート
本発明の清拭シートに用いられる基材シートは、織布又は不織布のいずれも使用することができるが、不織布の使用が好ましい。不織布は、繊維を織らずに絡み合わせたシートで、具体的には繊維を熱、物理的または化学的な作用によって接着または絡み合わせてシート状にしたものである。織布又は不織布の材料としては、ポリプロピレン繊維、ポリエチレンテレフタレート繊維、ポリアミド繊維、レーヨン繊維、アクリル繊維、ポリウレタン繊維、パルプ繊維(紙も含まれる)、及びこれらの2種以上からなる複合繊維が挙げられるが、基材シートに好ましい機能を付与するためには、複合繊維の使用が好ましい。
(2) Base Sheet The base sheet used in the cleaning sheet of the present invention can be either a woven fabric or a nonwoven fabric, but the use of a nonwoven fabric is preferred. A nonwoven fabric is a sheet in which fibers are intertwined without weaving, and specifically, fibers are bonded or intertwined together by heat, physical or chemical action to form a sheet. Examples of materials for woven or nonwoven fabrics include polypropylene fibers, polyethylene terephthalate fibers, polyamide fibers, rayon fibers, acrylic fibers, polyurethane fibers, pulp fibers (including paper), and composite fibers made of two or more of these, but the use of composite fibers is preferred in order to impart desirable functions to the base sheet.
複合繊維を使用する場合、吸湿性が高く、かつ肌触りが良好なレーヨン繊維が含まれていることが好ましい。好ましい複合繊維として、ポリエチレンテレフタレート繊維とレーヨン繊維からなる複合繊維が挙げられるが、この場合に複合繊維中にレーヨン繊維が40~60質量%含まれていることがより好ましい。また、他の好ましい複合繊維として、パルプ繊維とレーヨン繊維からなる複合繊維が挙げられるが、この場合には複合繊維中にレーヨン繊維が10~30質量%含まれていることがより好ましい。
基材シートの坪量は、20~80g/m2が好ましく、30~60g/m2がより好ましい。尚、基材シートは水系組成物を含浸させる前又は含浸させた後に紫外線照射等で殺菌処理されることが望ましい。
When using composite fibers, it is preferable that they contain rayon fibers, which have high hygroscopicity and a pleasant feel against the skin. A preferred composite fiber is one composed of polyethylene terephthalate fibers and rayon fibers, in which case it is more preferable that the composite fiber contains 40 to 60% by mass of rayon fibers. Another preferred composite fiber is one composed of pulp fibers and rayon fibers, in which case it is more preferable that the composite fiber contains 10 to 30% by mass of rayon fibers.
The basis weight of the base sheet is preferably 20 to 80 g/ m² , and more preferably 30 to 60 g/ m² . Furthermore, it is desirable that the base sheet be sterilized by ultraviolet irradiation or the like before or after impregnation with the aqueous composition.
(3)清拭シート
本発明が適用される清拭シートは、前記織布又は不織布からなる基材シートに水系組成物が含浸されたシートであり、乳幼児の尻拭き用、病人、老人、乳幼児等の身体清拭用に限定されず、更に、化粧落とし用シート、手拭き用シート、台所用拭き取りシート、OA製品用クリーナー等に広く使用することができる。
(3) Cleansing Sheet The cleansing sheet to which the present invention is applied is a sheet in which a water-based composition is impregnated into a base sheet made of the woven or nonwoven fabric, and is not limited to being used for wiping the bottom of infants, or for wiping the bodies of sick people, the elderly, or infants, but can be widely used as a makeup remover sheet, a hand towel sheet, a kitchen wipe sheet, a cleaner for office automation products, etc.
(3-1)基材シートへの水系組成物の含浸
前記基材シートに水系組成物を含浸させる方法としては、乾燥状態の基材シートに水系組成物をスプレーする方法、水系組成物を含むロールによる塗布方法、水系組成物への浸漬する方法等を例示することができるがこれらの方法に限定はされない。
(3-1) Impregnation of the base sheet with an aqueous composition Examples of methods for impregnating the base sheet with an aqueous composition include, but are not limited to, spraying the aqueous composition onto a dry base sheet, applying it using a roll containing the aqueous composition, and immersing the sheet in the aqueous composition.
本発明の清拭シートにおいて、基材シートへの水系組成物の含侵量は、清拭機能を発揮させる観点から、基材シートの乾燥質量換算100質量部に対し、100~300質量部が好ましく、150~270質量部がより好ましい。含侵量が前記100質量部未満では基材シート全体に水系組成物を含侵させることができず、拭き取に支障を生ずるおそれがあり、含侵量が前記300質量部を超えると水系組成物を基材シートに含侵しきれず、拭いた後の皮膚が濡れて不快感を生じ易くなるおそれがある。 In the present invention's cleaning sheet, the amount of aqueous composition impregnated into the base sheet is preferably 100 to 300 parts by mass, and more preferably 150 to 270 parts by mass, based on the dry mass of the base sheet, from the viewpoint of exhibiting the cleaning function. If the impregnation amount is less than 100 parts by mass, the aqueous composition cannot be impregnated into the entire base sheet, which may hinder wiping. If the impregnation amount exceeds 300 parts by mass, the aqueous composition cannot be fully impregnated into the base sheet, which may cause the skin to become wet and uncomfortable after wiping.
(3-2)清拭シートの水相部のpH
本発明の清拭シートにおける水相部のpH、すなわち水系組成物を基材シートに含浸させた後のほぼ平衡状態における、水相部のpHは、25℃において6.1以上6.6以下であることが好ましい。前記水相部のpHは、(株)堀場製作所製、LAQUA twin pHメータを用いて測定されたpH値である。
皮膚表面では、例えば善玉菌(Good bacteria)で皮膚常在菌(Skin-resident bacteria)である表皮ブドウ球菌が脂肪酸を分泌して皮膚表面を弱酸性に保ち雑菌やウイルスの侵入を防いでいる。一方、皮膚表面がアルカリ性になると悪玉菌(Bad bacteria)である黄色ブドウ球菌が活発になって、皮膚トラブルが生じ易くなるおそれがある。
(3-2) pH of the aqueous phase of the cleaning sheet
The pH of the aqueous phase in the cleaning sheet of the present invention, that is, the pH of the aqueous phase in a nearly equilibrium state after impregnating the base sheet with the aqueous composition, is preferably 6.1 or higher and 6.6 or lower at 25°C. The pH of the aqueous phase is the pH value measured using a LAQUA twin pH meter manufactured by Horiba, Ltd.
On the skin surface, beneficial bacteria such as Staphylococcus epidermidis, which are part of the skin's normal flora, secrete fatty acids to maintain a slightly acidic pH, preventing the invasion of harmful bacteria and viruses. On the other hand, if the skin surface becomes alkaline, harmful bacteria such as Staphylococcus aureus become more active, which can increase the likelihood of skin problems.
皮膚表面のpHは、個人差はあるが4.5~6.5程度の弱酸性に保たれていて、善玉菌である皮膚常在菌が棲みやすい環境となっている。また乳幼児の皮膚表面のpHは生後5~6週間後に6.0~7.0程度になること等から、清拭シートにおける水相部のpHを上記範囲に維持することが好ましい。pH調整剤を添加せずに、清拭シートにおける水相部のpHを抗菌剤成分であるベンザルコニウムクロリドとポリアミノプロピルビグアニド塩酸塩の配合割合により弱酸性に調整できることは本発明の特徴の一つである。 The pH of the skin surface is maintained at a slightly acidic level of approximately 4.5 to 6.5, although this varies from person to person, creating an environment where beneficial skin flora can easily thrive. Furthermore, since the pH of an infant's skin surface rises to approximately 6.0 to 7.0 after 5 to 6 weeks of age, it is preferable to maintain the pH of the aqueous phase in the cleansing sheet within this range. One of the features of this invention is that the pH of the aqueous phase in the cleansing sheet can be adjusted to a slightly acidic level by adjusting the ratio of the antibacterial components, benzalkonium chloride and polyaminopropyl biguanide hydrochloride, without the addition of a pH adjusting agent.
本発明の清拭シートを以下の実施例と比較例により具体的に説明するが、本発明は以下の実施例に限定されるものではない。本実施例と比較例において、清拭シート含侵用の水系組成物と、水系組成物が含侵された清拭シートに分けて説明する。 The present invention's cleaning sheet will be specifically described with reference to the following examples and comparative examples, but the present invention is not limited to these examples. In these examples and comparative examples, the aqueous composition for impregnating the cleaning sheet and the cleaning sheet impregnated with the aqueous composition will be described separately.
先ず、本実施例、比較例で使用した原材料、試料を以下に記載する。
(1)精製水
常水をイオン交換樹脂により精製して、電気伝導度が1μS/cm以下の精製水を調製した。
(2)保存性向上剤、可溶化剤
水系組成物に添加する成分として、以下に記載する保存性向上剤、可溶化剤を使用した。尚、pHの測定は、(株)堀場製作所製、HORIBA pH METER F-21を用いて行った。
(i)ベンザルコニウムクロリドは、市販品で、その1質量%水溶液のpHは7.91、10質量%水溶液のpHは8.93であった。
(ii)ポリアミノプロピルビグアニド塩酸塩は、市販品で、その1質量%水溶液のpHは3.26、10質量%水溶液のpHは3.45であり、重量平均分子量は2000~3000であった。
(iii)カプリン酸グリセリルは、市販品で、その性状はロウ状の塊であった。尚、該成分は、水に難溶のためpH測定は行わなかった。
(iv)ブチルカルバミン酸ヨウ化プロピニルは、市販品を用いた。
(v)ポリエチレングリコールは、市販品で、その数平均分子量は、200であった。
(vi)ポリプロピレングリコールは、市販品を用いた。
First, the raw materials and samples used in this example and comparative example are listed below.
(1) Purified water: Ordinary water was purified using an ion exchange resin to prepare purified water with an electrical conductivity of 1 μS/cm or less.
(2) Preservatives and Solubilizers The preservatives and solubilizers described below were used as components added to the aqueous composition. pH was measured using a HORIBA pH METER F-21 manufactured by HORIBA, Ltd.
(i) Benzalkonium chloride was a commercially available product, and the pH of its 1% by mass aqueous solution was 7.91, and the pH of its 10% by mass aqueous solution was 8.93.
(ii) Polyaminopropyl biguanide hydrochloride was a commercially available product, with a pH of 3.26 for a 1% by mass aqueous solution and a pH of 3.45 for a 10% by mass aqueous solution, and a weight-average molecular weight of 2000 to 3000.
(iii) Glyceryl caprate was a commercially available product, and its properties were those of a waxy mass. Since this component is poorly soluble in water, pH measurement was not performed.
(iv) Propynyl iodide butylcarbamate was a commercially available product.
(v) Polyethylene glycol was a commercially available product with a number-average molecular weight of 200.
(vi) A commercially available polypropylene glycol was used.
(3)基材シート
基材シートに使用した不織布は、坪量が32g/m2のレーヨンとポリエチレンテレフタレートからなる複合繊維のスパンレースで、該複合繊維中のレーヨン繊維の含有割合は40~60質量%であった。
(3) Base sheet The nonwoven fabric used for the base sheet was a spunlace composite fiber made of rayon and polyethylene terephthalate with a basis weight of 32 g/ m² , and the rayon fiber content in the composite fiber was 40 to 60% by mass.
[実施例1~9、比較例1~8]
1.水系組成物についての評価試験
清拭シート含侵用の水系組成物についての評価試験を行った。
1―1.水系組成物の調製
実施例1~9、比較例1~8において、清拭シート含侵用の水系組成物を調製した。
具体的には、各実施例と比較例に応じて保存性向上剤と、可溶化剤のそれぞれの所定量を上記精製水に溶解して、表1~3に示す水系組成物を調製した。尚、カプリン酸グリセリルは予め可溶化剤であるポリエチレングリコールに溶解して、水系組成物に添加した。比較例5で評価する水系組成物は可溶化剤が含まれていないので、ロウ状の固形物をすり潰して水系組成物に直接添加した。また、比較例8は、水系組成物がブランクの例であるので、水系組成物の代わりに上記精製水をそのまま使用した。
上記で調製した水系組成物について、下記の評価を行った。
[Examples 1-9, Comparative Examples 1-8]
1. Evaluation Tests of Aqueous Compositions Evaluation tests were conducted on aqueous compositions for impregnation of cleaning sheets.
1-1. Preparation of aqueous compositions In Examples 1 to 9 and Comparative Examples 1 to 8, aqueous compositions for impregnation of cleaning sheets were prepared.
Specifically, the aqueous compositions shown in Tables 1 to 3 were prepared by dissolving predetermined amounts of the preservative and solubilizer in the purified water according to each example and comparative example. Glyceryl caprate was pre-dissolved in polyethylene glycol, a solubilizer, before being added to the aqueous composition. Since the aqueous composition evaluated in Comparative Example 5 did not contain a solubilizer, a waxy solid was ground and added directly to the aqueous composition. Furthermore, in Comparative Example 8, since the aqueous composition was a blank example, the purified water was used as is instead of the aqueous composition.
The aqueous compositions prepared above were evaluated as follows.
1―2.水系組成物についての評価
実施例1~9、比較例1~8において、基材シートに含浸させる前の水系組成物について、以下に示す(1)pH測定、(2)白濁又は沈殿物の発生の有無の観察、(3)保存効力試験をそれぞれ行った。
(1)pH測定
実施例1~9、比較例1~4、8において、調製した水系組成物の常温(25℃)におけるpHを測定した。pH測定装置は、(株)堀場製作所製、HORIBA pH METER F-21を使用した。
pHの測定結果を表1-3に示した。実施例1~9の水系組成物において、常温(25℃)におけるpHは、3.47~3.83の範囲であった。表1~3から、ポリアミノプロピルビグアニド塩酸塩の含有量(b2)とベンザルコニウムクロリドの含有量(b1)との質量比(b2/b1)が増加する程、水系組成物のpH値が低くなることが確認された。
1-2. Evaluation of Aqueous Compositions In Examples 1-9 and Comparative Examples 1-8, the aqueous compositions were subjected to the following tests before being impregnated into the substrate sheets: (1) pH measurement, (2) observation for the presence or absence of turbidity or precipitate formation, and (3) preservative efficacy test.
(1) pH measurement In Examples 1 to 9 and Comparative Examples 1 to 4 and 8, the pH of the prepared aqueous compositions was measured at room temperature (25°C). The pH measuring device used was a HORIBA pH METER F-21 manufactured by HORIBA, Ltd.
The pH measurement results are shown in Table 1-3. In the aqueous compositions of Examples 1-9, the pH at room temperature (25°C) was in the range of 3.47-3.83. From Tables 1-3, it was confirmed that the pH value of the aqueous composition decreased as the mass ratio (b2/b1) of the polyaminopropyl biguanide hydrochloride content (b2) to the benzalkonium chloride content (b1) increased.
(2)白濁又は沈殿物の発生の有無の観察
実施例1~9、比較例1~7において、保存性向上剤と可溶化剤を表1~3に示す濃度になるように調製した水系組成物を充分に撹拌した後に静置して、白濁又は沈殿物の発生の有無を目視で観察した。白濁又は沈殿物の発生の有無の観察結果を表1~3に示した。可溶化剤が配合されていない、比較例5においては、水系組成物に白濁ないし沈殿の発生が観察された。
(2) Observation of the presence or absence of turbidity or precipitate In Examples 1 to 9 and Comparative Examples 1 to 7, aqueous compositions prepared with the preservative and solubilizer at the concentrations shown in Tables 1 to 3 were thoroughly stirred and then allowed to stand, and the presence or absence of turbidity or precipitate was visually observed. The results of the observation of the presence or absence of turbidity or precipitate are shown in Tables 1 to 3. In Comparative Example 5, which did not contain a solubilizer, turbidity or precipitate was observed in the aqueous composition.
(3)保存効力試験
実施例1~9において、第17改正日本薬局方の「保存効力試験法」に記載された試験法に準拠して、水系組成物の保存効力試験を行った。
(3) Preservative efficacy test In Examples 1 to 9, the preservative efficacy test of the aqueous compositions was performed in accordance with the test method described in the "Preservative Efficacy Test Method" of the 17th edition of the Japanese Pharmacopoeia.
(i)試験方法
保存効力試験は、一定数の細菌、真菌を水系組成物にそれぞれ混入させ、その数を経時的に測定して防腐効果を確認する試験である。
被検菌株として規定されている、下記の3種の細菌及び、2種の真菌をそれぞれ用いて接種し、7日後、14日後、28日後の生菌数を測定した。
抗菌性試験の被検菌株(細菌)
(a)大腸菌(NBRC 3972)
(b)黄色ブドウ球菌(NBRC 12732)
(c)緑膿菌(12689)
抗カビ性試験の被検菌株(真菌)
(d)カンジタ(NBRC 1385)
(e)クロコウジカビ(NBRC 105649)
(i) Test method The preservative efficacy test is a test in which a certain number of bacteria and fungi are mixed into an aqueous composition, and the number is measured over time to confirm the preservative effect.
The following three types of bacteria and two types of fungi, designated as test strains, were inoculated, and the number of viable cells was measured after 7, 14, and 28 days.
Test bacterial strains (bacteria) for antimicrobial testing
(a) Escherichia coli (NBRC 3972)
(b) Staphylococcus aureus (NBRC 12732)
(c) Pseudomonas aeruginosa (12689)
Test strains (fungi) for antifungal testing
(d) Candida (NBRC 1385)
(e) Aspergillus oryzae (NBRC 105649)
(ii)評価方法、評価結果
評価は、接種菌数の減少率により行った。減少率の算出方法を以下に示す。
減少率(%)=[((初発菌数)-(7、14、28日後の生菌数))/初発菌数]×100
実施例1~9で調製した水系組成物についての評価結果を表1、2に示した。
尚、表1、2において、保存効力試験におけるブランクの欄は、水系組成物の代わりに精製水に上記細菌、真菌を所定数接種した後、7日間経過後の生菌数を示す。
実施例1~5においては、細菌、真菌をそれぞれ接種した後、7日後、14日後、28日の生菌数を測定し、実施例6~9では7日後の細菌数を測定した。
いずれの上記被検菌株を用いた保存効力試験においても、7日後、及び7日経過以降の生菌減少率は、100%であったので、実施例1~9で調製した水系組成物は優れた抗菌性・防カビ性を有していることが確認された。
(ii) Evaluation method and evaluation results The evaluation was performed based on the rate of reduction in the number of inoculum. The method for calculating the rate of reduction is shown below.
Reduction rate (%) = [((Initial bacterial count) - (Viable bacterial count after 7, 14, and 28 days)) / Initial bacterial count] × 100
The evaluation results for the aqueous compositions prepared in Examples 1 to 9 are shown in Tables 1 and 2.
In Tables 1 and 2, the blank column in the preservation efficacy test indicates the number of viable bacteria after 7 days, following the inoculation of a predetermined number of the above-mentioned bacteria and fungi into purified water instead of the aqueous composition.
In Examples 1-5, the number of viable bacteria and fungi was measured after inoculation, at 7, 14, and 28 days, respectively. In Examples 6-9, the number of bacteria was measured after 7 days.
In all of the preservation efficacy tests using the above-mentioned test bacterial strains, the rate of viable cell reduction after 7 days and beyond was 100%, confirming that the aqueous compositions prepared in Examples 1 to 9 possess excellent antibacterial and antifungal properties.
2.清拭シートについての評価試験、及び結果
実施例1~9、比較例1~4、6、7で調製した水系組成物を基材シートに含侵させて清拭シート試験片を作製し、得られた清拭シート試験片について、以下の保存安定性試験と皮膚刺激性に関する評価を行った。
(i)保存安定性試験
保存安定性試験として、抗菌性試験(JIS L 1902に準拠)、抗カビ性試験(JIS L 1921に準拠)、及びカビ抵抗性試験(JIS Z 2911に準拠)を行った。
清拭シート試験片の抗カビ性の評価について、実施例1~4では、比較例に対する優位性を明確化するために定量的な抗カビ性の評価である、「抗カビ性試験(JIS L 1921に準拠)」を行った。また、実施例5~9では、比較例に対する優位性が想定されていたので、定性的な抗カビ性の評価である、「カビ抵抗性試験(JIS Z 2911に準拠)」を行った。
(ii)皮膚刺激性に関する評価
皮膚刺激性試験に関する評価として、清拭シート試験片の水相部のpH測定、及び皮膚一次刺激性試験を行った。
2. Evaluation tests and results for the cleansing sheets Cleansing sheet test pieces were prepared by impregnating a base sheet with the aqueous compositions prepared in Examples 1 to 9 and Comparative Examples 1 to 4, 6, and 7. The obtained cleansing sheet test pieces were subjected to the following storage stability tests and evaluations regarding skin irritation.
(i) Storage stability test As part of the storage stability test, an antimicrobial test (in accordance with JIS L 1902), an antifungal test (in accordance with JIS L 1921), and a mold resistance test (in accordance with JIS Z 2911) were conducted.
Regarding the evaluation of the antifungal properties of the cleaning sheet test pieces, in Examples 1 to 4, a quantitative evaluation of antifungal properties, the "Antifungal Properties Test (in accordance with JIS L 1921)," was performed to clarify the superiority over the comparative examples. In Examples 5 to 9, since superiority over the comparative examples was anticipated, a qualitative evaluation of antifungal properties, the "Mold Resistance Test (in accordance with JIS Z 2911)," was performed.
(ii) Evaluation of skin irritation As part of the evaluation of skin irritation tests, the pH of the aqueous phase of the cleansing sheet test piece was measured, and a primary skin irritation test was performed.
2-1.清拭シート試験片の作製
所定のサイズに切断した上記不織布シートに、上記で調製した水系組成物を、ハンドスプレーで含浸量が80g/m2になるように均一に噴霧して、実施例1~9、及び比較例1~4、6~8でそれぞれ評価する清拭シート試験片を作製した。尚、不織布シートに水系組成物を含浸させた後に紫外線により殺菌処理を行った。
2-1. Preparation of Cleaning Sheet Test Specimens Cleaning sheet test specimens were prepared by uniformly spraying the aqueous composition prepared above onto the nonwoven fabric sheets cut to a predetermined size, using a hand sprayer, so that the impregnation amount was 80 g/ m² . These specimens were to be evaluated in Examples 1-9 and Comparative Examples 1-4 and 6-8, respectively. After impregnating the nonwoven fabric sheets with the aqueous composition, they were sterilized using ultraviolet light.
2-2.清拭シート試験片についての評価試験
(1)清拭シート試験片の水相部のpH測定
実施例1~9、比較例1~4、8において調製した水系組成物をそれぞれ基材シートに含浸させて清拭シート試験片を作製した後、約60分放置した。その後、該清拭シート試験片をパディング加工機(マングル)で絞った抽出液を、室温(25℃)に維持し、pH測定装置((株)堀場製作所製、LAQUA twin pHメータ)を用いてpH測定を行った。測定結果を表4~6に示した。
実施例1~9で調製した水系組成物が含侵された清拭シート試験片の水相部のpHはいずれも6.1~6.6の範囲内であった。
2-2. Evaluation Test of Cleaning Sheet Test Pieces (1) pH Measurement of the Aqueous Phase of Cleaning Sheet Test Pieces Cleaning sheet test pieces were prepared by impregnating the base sheets with the aqueous compositions prepared in Examples 1 to 9 and Comparative Examples 1 to 4 and 8, and then left to stand for approximately 60 minutes. After that, the extract obtained by squeezing the cleaning sheet test pieces with a padding machine (mangle) was maintained at room temperature (25°C), and the pH was measured using a pH measuring device (LAQUA twin pH meter, manufactured by Horiba, Ltd.). The measurement results are shown in Tables 4 to 6.
The pH of the aqueous phase of the cleaning sheet test pieces impregnated with the aqueous compositions prepared in Examples 1 to 9 was in the range of 6.1 to 6.6 in all cases.
(2)抗菌性試験
実施例1~9、比較例1~4、6~8での評価用に調製した水系組成物をそれぞれ基材シートに含浸させて得た清拭シート試験片について、JIS L 1902(2015)に準拠して抗菌性試験を行った。JIS L 1902は、抗菌性繊維の抗菌性を評価する定性試験で、不織布を含む全ての抗菌性繊維製品の抗菌活性の評価方法について規定している。
(i)試験の方法
供試細菌には、下記の2種を用いた。
大腸菌(NBRC 3301)
黄色ブドウ球菌(NBRC 12732)
寒天培地に大腸菌、黄色ブドウ球菌をそれぞれ加えた培地をシャーレに入れて固め、清拭シート試験片をシャーレの中央に置いた。このシャーレを37℃で48時間放置し、培地上に菌が繁殖した状況で、試験片の周囲に菌が繁殖しない阻止帯(ハロー)形成幅の4方の幅(mm)を測定して、その平均値を求めた。尚、表6において、比較例6、7についてのみ、評価結果としてハローの有無を記載した。
(2) Antimicrobial Test The cleaning sheet test pieces obtained by impregnating the base sheets with the aqueous compositions prepared for evaluation in Examples 1 to 9 and Comparative Examples 1 to 4 and 6 to 8 were subjected to antimicrobial tests in accordance with JIS L 1902 (2015). JIS L 1902 is a qualitative test for evaluating the antimicrobial properties of antimicrobial fibers and specifies the method for evaluating the antimicrobial activity of all antimicrobial fiber products, including nonwoven fabrics.
(i) Test method The following two types of bacteria were used as test subjects.
Escherichia coli (NBRC 3301)
Staphylococcus aureus (NBRC 12732)
E. coli and Staphylococcus aureus were added to agar plates, and these plates were placed in petri dishes and allowed to solidify. A cleansing sheet test piece was placed in the center of the petri dish. The petri dish was left at 37°C for 48 hours, and once the bacteria had grown on the medium, the width (mm) of the inhibition zone (halo) formed around the test piece where bacteria did not grow was measured on all four sides, and the average value was calculated. Note that in Table 6, only for Comparative Examples 6 and 7, the presence or absence of a halo is indicated as an evaluation result.
(ii)評価結果
試験菌である、大腸菌と黄色ブドウ球菌について測定したハロー幅を表4~6に示した。JIS L 1902に基づくハローの有無の判定基準は、下記の通りである。
ハローの幅の平均値>0 のとき:ハローあり
ハローの幅の平均値=0 のとき:ハローなし
実施例1から9において、抗菌性試験の評価は、いずれも「ハローあり」の判定であった。
(ii) Evaluation Results The halo widths measured for the test bacteria, Escherichia coli and Staphylococcus aureus, are shown in Tables 4 to 6. The criteria for determining the presence or absence of a halo, based on JIS L 1902, are as follows.
When the average width of the halo > 0: Halo present When the average width of the halo = 0: Halo absent In Examples 1 to 9, the antibacterial test evaluation was "Halo present" in all cases.
(3)抗カビ性試験
実施例1~4、比較例4での評価用に調製した水系組成物をそれぞれ基材シートに含浸させて得た清拭シート試験片について、JIS L 1921(2015)に準拠して抗カビ性試験を行った。抗カビ性試験は、比較的短時間でカビを一定量死滅させる抗かび力を調べる、定量的な試験方法である。
(3) Antifungal Test The cleaning sheet test pieces obtained by impregnating the base sheet with the aqueous compositions prepared for evaluation in Examples 1 to 4 and Comparative Example 4 were subjected to an antifungal test in accordance with JIS L 1921 (2015). The antifungal test is a quantitative test method that investigates the antifungal power to kill a certain amount of mold in a relatively short time.
(i)試験の概要
予め培養した試験カビから胞子を採取して、試験用胞子懸濁液を調製する。次に、該験胞子懸濁液を清拭シート試験片と、比較対照試料(綿標準布)とにそれぞれ接種し、25℃で18、24時間培養した後のATP量を測定することにより、試料上に生存しているカビの量を求める。清拭シート試験片と対照試料のかびの量を比較することで、かびの増殖をどれだけ抑えることができたかを示す、「抗かび活性値」を算出する。尚、ATP量の測定とは、生物の細胞内に存在するATP(アデノシン三リン酸)を酵素等により発光させて、その発光量を測定することをいう。この発光量は細胞内のATP量が多いほど発光量は増加する。
(i) Overview of the test Spores are collected from pre-cultured test molds to prepare a test spore suspension. Next, the test spore suspension is inoculated onto a cleansing sheet test piece and a control sample (cotton standard cloth), respectively, and the amount of ATP is measured after incubation at 25°C for 18 and 24 hours to determine the amount of mold surviving on the sample. By comparing the amount of mold on the cleansing sheet test piece and the control sample, the "antifungal activity value" is calculated, which indicates how well mold growth was suppressed. Note that the measurement of ATP amount refers to making ATP (adenosine triphosphate) present in the cells of living organisms emit light using enzymes, etc., and measuring the amount of light emitted. The amount of light emitted increases as the amount of ATP in the cell increases.
「抗カビ活性値」は下式から求められる。
抗カビ活性値(Aa):(Fb-Fa)-(Fc-Fo)
Fb:未処理綿繊維42時間培養後のATP量の算術平均の常用対数値
Fa:未処理綿繊維接種直後のATP量の算術平均の常用対数値
Fc:清拭シート試験片42時間培養後のATP量の算術平均の常用対数値
Fo:清拭シート試験片接種直後のATP量の算術平均の常用対数値
The "antifungal activity value" can be calculated using the following formula.
Antifungal activity value (Aa): (Fb - Fa) - (Fc - Fo)
Fb: Common logarithm of the arithmetic mean of ATP levels after 42 hours of incubation of untreated cotton fibers Fa: Common logarithm of the arithmetic mean of ATP levels immediately after inoculation of untreated cotton fibers Fc: Common logarithm of the arithmetic mean of ATP levels after 42 hours of incubation of cleansing sheet test pieces Fo: Common logarithm of the arithmetic mean of ATP levels immediately after inoculation of cleansing sheet test pieces
(ii) 試験カビ種
試験カビ種として、下記のカビを選択した。
クロコウジカビ(NBRC 105649)
(iii)評価基準、評価結果
抗カビ活性値(Aa)は、値が大きい程、抗かび性能が高いことを示しており、評価基準からは2.0以上が抗カビ性有りされる。
実施例1~4、比較例4で算出された抗かび活性値(Aa)を表4に示す。表4から、実施例1~4の清拭シート試験片は、いずれも抗カビ活性値(Aa)が2.0以上であり、比較例4の清拭シート試験片と対比して、抗かび性に優れていることが確認された。
(ii) Test mold species The following molds were selected as test mold species.
Aspergillus oryzae (NBRC 105649)
(iii) Evaluation criteria and results The antifungal activity value (Aa) indicates that the higher the value, the higher the antifungal performance. According to the evaluation criteria, a value of 2.0 or higher indicates antifungal properties.
Table 4 shows the antifungal activity values (Aa) calculated for Examples 1-4 and Comparative Example 4. From Table 4, it can be seen that the cleaning sheet test pieces of Examples 1-4 all had an antifungal activity value (Aa) of 2.0 or higher, and were found to be superior in antifungal properties compared to the cleaning sheet test piece of Comparative Example 4.
(4)カビ抵抗性試験
前記水系組成物をそれぞれ基材シートに含浸させて得た清拭シート試験片について、カビ抵抗性試験(JIS Z 2911(2018))に基づく評価を行った。カビ抵抗性試験は、試験片のカビに対する抵抗性を評価する定性的な試験であり、比較的長い培養期間での試験片のカビ抵抗性の評価を行うことが可能である。
(4) Mold Resistance Test The cleaning sheet test pieces obtained by impregnating each of the aqueous compositions onto a base sheet were evaluated according to the mold resistance test (JIS Z 2911 (2018)). The mold resistance test is a qualitative test that evaluates the resistance of the test piece to mold, and it is possible to evaluate the mold resistance of the test piece over a relatively long incubation period.
(i)試験の概要
実施例5~9、比較例1~3、8での評価用に調製した水系組成物をそれぞれ基材シートに含浸させて得た清拭シート試験片について、カビ抵抗性試験を行った。
尚、上記実施例1~4、比較例4においては上記抗カビ性試験で抗カビ性は評価済であるので、カビ抵抗性試験は省略した。
試験片をシャーレ内の無機塩培地上に置き、下記カビの胞子懸濁液を試験片の表面に均等に吹き付けて、28±4℃で4週間培養した後、前記試験片上での菌糸の発育状態を肉眼および顕微鏡で観察した。
(i) Overview of the test Mold resistance tests were performed on cleaning sheet test pieces obtained by impregnating a base sheet with the aqueous compositions prepared for evaluation in Examples 5-9 and Comparative Examples 1-3 and 8.
In addition, since the antifungal properties were already evaluated in the antifungal properties test described above for Examples 1 to 4 and Comparative Example 4, the mold resistance test was omitted.
The test specimens were placed on an inorganic salt medium in a petri dish, and the spore suspension of the following mold was evenly sprayed onto the surface of the specimens. After incubation at 28±4°C for 4 weeks, the growth of mycelium on the specimens was observed with the naked eye and under a microscope.
(ii)供試カビ
下記の(a)1種カビと、(b)3種混合カビを用いた。
(a)アスペルギルス ニゲル (Aspergillus niger) NBRC 105649
(b)3種混合
ペニシリウム シトリナム(Penicillium citrinum) (NBRC 6352)
ケトミウム グロボスム(Chaetomium globosum) (NBRC 6347)
ミロテシウム ベルカリア(Myrothecium verrucaria) (NBRC 6113)
(ii) Test molds The following (a) single type of mold and (b) a mixture of three types of mold were used.
(a) Aspergillus niger NBRC 105649
(b) Mixed of three species: Penicillium citrinum (NBRC 6352)
Chaetomium globosum (NBRC 6347)
Myrothecium verrucaria (NBRC 6113)
(iii)判定基準、評価結果
JIS Z 2911(2018)に基づく、かびの発育状態の判定基準は下記の3段階で示されており、「0又は1」の評価をかび抵抗性有とした。
0:試験片の接種した部分に菌糸の発育が認められない。
1:試験片の接種した部分に認められた菌糸の面積が全面積の1/3を超えない。
2:試験片の接種した部分に認められた菌糸の面積が全面積の1/3を超える。
上記判定基準に基づく、評価結果を表5、6に示した。表5、6から、実施例5~9で作製した清拭シート試験片においては、かび発育状態の判定はいずれも1であり、比較例1~3、8で作製した清拭シート試験片と対比してかび抵抗性に優れていることが確認された。
(iii) Criteria for evaluation, evaluation results
Based on JIS Z 2911 (2018), the criteria for determining the state of mold growth are shown in the following three stages, with a rating of "0 or 1" indicating mold resistance.
0: No mycelial growth was observed in the inoculated area of the test specimen.
1. The area of mycelium observed in the inoculated portion of the test specimen does not exceed 1/3 of the total area.
2. The area of mycelium observed in the inoculated portion of the test specimen exceeds 1/3 of the total area.
The evaluation results based on the above criteria are shown in Tables 5 and 6. From Tables 5 and 6, it can be seen that the mold growth status of the cleaning sheet test pieces prepared in Examples 5 to 9 was all judged as 1, and it was confirmed that they had superior mold resistance compared to the cleaning sheet test pieces prepared in Comparative Examples 1 to 3 and 8.
(5)皮膚一次刺激性試験
日本化粧品工業連合会による「化粧品の安全性評価に関する指針」に準拠した皮膚一次刺激性試験を行った。
実施例6での評価用に調製した水系組成物を含侵させて作製した清拭シート試験片、及び実施例6で調製した水系組成物において、ベンザルコニウムクロリドを0.0500質量%、ポリアミノプロピルビグアニド塩酸塩を0.0500質量%、カプリン酸グリセリルを0.0300質量%、ポリエチレングリコールを0.0100質量%とした以外は、実施例6で調製したと同様の水系組成物(実施例11)を含侵させて作製した清拭シート試験片について、皮膚一次刺激性試験を行った。
(5) Primary skin irritation test A primary skin irritation test was conducted in accordance with the "Guidelines for Safety Evaluation of Cosmetics" issued by the Japan Cosmetic Industry Association.
A primary skin irritation test was performed on a cleansing sheet test piece prepared by impregnating it with the aqueous composition prepared for evaluation in Example 6, and on a cleansing sheet test piece prepared by impregnating it with the same aqueous composition as prepared in Example 6 (Example 11), except that the aqueous composition prepared in Example 6 contained 0.0500% by mass of benzalkonium chloride, 0.0500% by mass of polyaminopropyl biguanide hydrochloride, 0.0300% by mass of glyceryl caprate, and 0.0100% by mass of polyethylene glycol.
(i)試験方法
健康な男性と女性の被験者20名に、皮膚テスト用テープ(評価用清拭シート試験片)を被験者の背部正常皮膚部に貼付した。貼付24時間後に、皮膚テスト用テープを取り除いて皮膚の症状を目視で確認し、下記評価基準で評価した。
反応なし:0.0点
わずかな紅斑:0.5点
明らかな紅斑:1.0点
紅斑および浮腫または丘疹:2.0点
紅斑および浮腫・丘疹および小水疱:3.0点
大水疱:4.0点
(i) Test Method Twenty healthy male and female subjects had skin test tapes (evaluation cleansing sheets) applied to the normal skin on their backs. After 24 hours, the skin test tapes were removed and the skin condition was visually inspected and evaluated according to the following evaluation criteria.
No reaction: 0.0 points Slight erythema: 0.5 points Obvious erythema: 1.0 points Erythema and edema or papules: 2.0 points Erythema and edema/papules and vesicles: 3.0 points Large vesicles: 4.0 points
(ii)皮膚刺激指数と判定
各被験者の評価点を求め、下記式により皮膚刺激指数を求めた。
皮膚刺激指数=(評点総和/被験者数)×100
次に、求メータ皮膚刺激指数から、香粧品の皮膚刺激指数の分類(安全品:5.0以下、許容品:5.0~15.0、要改良品:15.0~30.0、危険品:30.0以上)により安全性を判定した。
評価の結果、実施例6、11で作製した清拭シート試験片の皮膚刺激指数は、いずれも2.5以下を示し、「安全品」に分類された。
(ii) Skin irritation index and determination The evaluation score for each subject was determined, and the skin irritation index was calculated using the following formula.
Skin irritation index = (Sum of scores / Number of subjects) × 100
Next, the safety of the cosmetic product was determined based on the skin irritation index measured by the meter, according to the classification of skin irritation indices (safe product: 5.0 or less, acceptable product: 5.0 to 15.0, product requiring improvement: 15.0 to 30.0, dangerous product: 30.0 or more).
The evaluation results showed that the skin irritation index of the cleansing sheet test pieces prepared in Examples 6 and 11 was 2.5 or less in all cases, and they were classified as "safe products."
Claims (8)
前記水系組成物は、精製水中に、保存性向上剤として、抗菌剤成分であるベンザルコニウムクロリドとポリアミノプロピルビグアニド塩酸塩、及び防カビ剤成分であるカプリン酸グリセリル、
並びに可溶化剤として、カプリン酸グリセリルを可溶化させる溶剤が含まれていて、
前記水系組成物における、ベンザルコニウムクロリドの含有量(b1)が0.030質量%以上0.050質量%以下、ポリアミノプロピルビグアニド塩酸塩の含有量(b2)が0.025質量%以上0.070質量%以下、カプリン酸グリセリルの含有量(c1)が0.003質量%以上0.050質量%以下、であり、
前記清拭シートにおける水相部のpHが弱酸性であり、
更に、前記水系組成物における、精製水の濃度が99.85質量%以上99.92質量%以下である、ことを特徴とする清拭シート。 A cleaning sheet comprising a base sheet made of woven or nonwoven fabric impregnated with an aqueous composition containing a preservative enhancer and a solubilizer,
The aforementioned aqueous composition contains, in purified water, benzalkonium chloride and polyaminopropyl biguanide hydrochloride as preservatives, and glyceryl caprate as an antifungal agent.
Furthermore, it contains a solvent that solubilizes glyceryl caprate as a solubilizing agent.
In the aqueous composition, the content of benzalkonium chloride (b1) is 0.030% by mass or more and 0.050% by mass or less, the content of polyaminopropyl biguanide hydrochloride (b2) is 0.025% by mass or more and 0.070% by mass or less, and the content of glyceryl caprate (c1) is 0.003% by mass or more and 0.050% by mass or less.
The pH of the aqueous phase in the aforementioned cleaning sheet is weakly acidic.
Furthermore, the cleaning sheet is characterized in that the concentration of purified water in the aqueous composition is 99.85% by mass or more and 99.92% by mass or less.
ベンザルコニウムクロリドの含有量(b1)とポリアミノプロピルビグアニド塩酸塩の含有量(b2)の合計量(b1+b2)が0.060質量%以上0.105質量%以下であり、
かつ、ポリアミノプロピルビグアニド塩酸塩の含有量(b2)とベンザルコニウムクロリドの含有量(b1)との質量比(b2/b1)が0.625以上2.00以下である、
請求項1に記載の清拭シート。 In the aqueous composition,
The total amount of benzalkonium chloride (b1) and polyaminopropyl biguanide hydrochloride (b2) (b1 + b2) is 0.060% by mass or more and 0.105% by mass or less.
Furthermore, the mass ratio (b2/b1) of the polyaminopropyl biguanide hydrochloride content (b2) to the benzalkonium chloride content (b1) is 0.625 or more and 2.00 or less.
The cleaning sheet according to claim 1.
防カビ剤成分であるカプリン酸グリセリルの含有量(c1)と、抗菌剤成分であるベンザルコニウムクロリドの含有量(b1)とポリアミノプロピルビグアニド塩酸塩の含有量(b2)の合計量(b1+b2)との質量比(c1/(b1+b2))が、0.035以上0.833以下である、
請求項1又は2に記載の清拭シート。 In the aqueous composition,
The mass ratio (c1/(b1+b2)) of the amount of glyceryl caprate (c1), an antifungal agent component, and the total amount of benzalkonium chloride (b1) and polyaminopropyl biguanide hydrochloride (b2), both antibacterial agents (b1+b2), is between 0.035 and 0.833.
A cleaning sheet according to claim 1 or 2.
請求項1から3のいずれかに記載の清拭シート。 In the aqueous composition, the mass ratio (d1/c1) of the content of the solvent that solubilizes glyceryl caprate (d1) to the content of glyceryl caprate, which is an antifungal agent component (c1), is 0.60 or more and 2.14 or less.
A cleaning sheet according to any one of claims 1 to 3.
請求項1から4のいずれかに記載の清拭シート。 In the aqueous composition, the solvent for solubilizing glyceryl caprate is a polyether that is liquid at room temperature (15-25°C) and has OH-terminated groups.
A cleaning sheet according to any one of claims 1 to 4.
請求項1から5のいずれかに記載の清拭シート。 In the aqueous composition, the solvent for solubilizing glyceryl caprate is polyethylene glycol having a number average molecular weight of 100 to 600.
A cleaning sheet according to any one of claims 1 to 5.
請求項1から6のいずれかに記載の清拭シート。 The pH of the aqueous phase portion of the cleaning sheet at 25°C is 6.1 or higher and 6.6 or lower.
A cleaning sheet according to any one of claims 1 to 6.
請求項1から7のいずれかに記載の清拭シート。
The aforementioned cleansing sheet is for wiping the bottom of an infant, or for wiping the body of a sick person, the elderly, or an infant.
A cleaning sheet according to any one of claims 1 to 7.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021027953 | 2021-02-24 | ||
| JP2021027953 | 2021-02-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022129384A JP2022129384A (en) | 2022-09-05 |
| JP7837658B2 true JP7837658B2 (en) | 2026-03-31 |
Family
ID=83048941
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022023266A Active JP7837657B2 (en) | 2021-02-24 | 2022-02-17 | water-based composition |
| JP2022023267A Active JP7837658B2 (en) | 2021-02-24 | 2022-02-17 | Cleansing wipes |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022023266A Active JP7837657B2 (en) | 2021-02-24 | 2022-02-17 | water-based composition |
Country Status (3)
| Country | Link |
|---|---|
| JP (2) | JP7837657B2 (en) |
| TW (1) | TW202233155A (en) |
| WO (1) | WO2022181457A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7785716B2 (en) * | 2022-05-30 | 2025-12-15 | ユニ・チャーム株式会社 | Wet wipes packaging and chemical solution for wet wipes |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006206540A (en) | 2005-01-31 | 2006-08-10 | Hisamitsu Pharmaceut Co Inc | Sheet-like pack and method for producing the same |
| JP2008247786A (en) | 2007-03-29 | 2008-10-16 | Naris Cosmetics Co Ltd | External preparation for skin |
| WO2015125332A1 (en) | 2014-02-20 | 2015-08-27 | 株式会社マンダム | Cleansing sheet and cleansing composition |
| JP2019216843A (en) | 2018-06-15 | 2019-12-26 | 大王製紙株式会社 | Wet sheet |
| JP2021003399A (en) | 2019-06-27 | 2021-01-14 | 大和化学工業株式会社 | Preservative of damp washcloth or wet tissue |
-
2022
- 2022-02-17 JP JP2022023266A patent/JP7837657B2/en active Active
- 2022-02-17 JP JP2022023267A patent/JP7837658B2/en active Active
- 2022-02-17 WO PCT/JP2022/006490 patent/WO2022181457A1/en not_active Ceased
- 2022-02-23 TW TW111106494A patent/TW202233155A/en unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006206540A (en) | 2005-01-31 | 2006-08-10 | Hisamitsu Pharmaceut Co Inc | Sheet-like pack and method for producing the same |
| JP2008247786A (en) | 2007-03-29 | 2008-10-16 | Naris Cosmetics Co Ltd | External preparation for skin |
| WO2015125332A1 (en) | 2014-02-20 | 2015-08-27 | 株式会社マンダム | Cleansing sheet and cleansing composition |
| JP2019216843A (en) | 2018-06-15 | 2019-12-26 | 大王製紙株式会社 | Wet sheet |
| JP2021003399A (en) | 2019-06-27 | 2021-01-14 | 大和化学工業株式会社 | Preservative of damp washcloth or wet tissue |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022181457A1 (en) | 2022-09-01 |
| JP2022129383A (en) | 2022-09-05 |
| JP7837657B2 (en) | 2026-03-31 |
| JP2022129384A (en) | 2022-09-05 |
| TW202233155A (en) | 2022-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100929469B1 (en) | Antimicrobial agents | |
| US12486996B2 (en) | Antimicrobial composition including an acyl lactylate and a glycol and methods of inhibiting microbial growth utilizing the same | |
| TWI603698B (en) | Aqueous composition for impregnation into fiber sheet | |
| KR20150115757A (en) | Antimicrobial compositions, wipes, and methods | |
| JP6448376B2 (en) | Lotion | |
| JP7837658B2 (en) | Cleansing wipes | |
| WO2020027797A1 (en) | Composition including an antimicrobial boosting agent including an amphocarboxylate and methods of increasing the antimicrobial effectiveness of a composition | |
| KR102431631B1 (en) | Antibacterial composition containing dihydroxamic acid and method for inhibiting microbial growth using same | |
| CN102037989B (en) | Aqueous compositions for disinfection and/or sterilization | |
| EP4098731A1 (en) | Wet wipes with improved preservative properties | |
| US20220347128A1 (en) | Antimicrobial solutions | |
| JP2002233471A (en) | Wet tissue | |
| KR101320599B1 (en) | Antiseptic free and anti-biotic wet tissue | |
| WO2018199303A1 (en) | Sheet preparation containing miconazole and/or miconazole nitrate | |
| EP4632055A1 (en) | Wet wipes with improved preservative properties | |
| CN103210956A (en) | Cleaning wipes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AA64 | Notification of invalidation of claim of internal priority (with term) |
Free format text: JAPANESE INTERMEDIATE CODE: A241764 Effective date: 20220310 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220422 |
|
| RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7421 Effective date: 20230519 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20230519 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250120 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20251111 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260106 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20260317 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260317 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7837658 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |